The Patent Finder

Terms ending in 2036

Abraxis Bioscience, LLC

Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,705,070Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 10,900,951Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Paclitaxel
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 11,320,416Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug
In force
 · Medium confidence
Abraxis Bioscience, LLCIn forceMedium confidence
US 12,061,183Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug
In force
 · Medium confidence
Abraxis Bioscience, LLCIn forceMedium confidence
US 10,527,604Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Paclitaxel
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 10,973,806Methods of Treating Epithelioid Cell Tumors Comprising Administering a Composition Comprising Nanoparticles Comprising an Mtor Inhibitor and an Albumin
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited